In focus · trending topic

GR-MD-02

31 stories · following the connections

Galectin Therapeutics to Present at 2nd Annual NASH Summit 2018

By Nasdaq OMXApr 18, 2018, 12:00 PM UTC

Galectin Therapeutics Late-Breaker Presentation at The International Liver Congress Reinforces and Extends the Positive Effects of GR-MD-02 in Patients With NASH Cirrhosis

By Nasdaq OMXApr 16, 2018, 12:00 PM UTC

Galectin Therapeutics to Present Late-Breaker Oral Presentation at The International Liver Congress 2018

By Nasdaq OMXApr 4, 2018, 1:00 PM UTC

Galectin Therapeutics Reports 2017 Financial Results and Provides Business Update

By Nasdaq OMXMar 29, 2018, 12:10 PM UTC

Galectin Therapeutics to Present at Two International Conferences in March

By Nasdaq OMXMar 9, 2018, 1:30 PM UTC

Galectin Therapeutics to Present at 30th Annual ROTH Conference

By Nasdaq OMXFeb 28, 2018, 9:35 PM UTC

Galectin Therapeutics to Present at BIO CEO & Investor Conference

By Nasdaq OMXFeb 6, 2018, 2:15 PM UTC

Galectin Therapeutics Granted Patents in China and Japan that Support NASH and Cancer Immunotherapy Clinical Development Programs

By Nasdaq OMXJan 25, 2018, 1:31 PM UTC